Article Information
PubMed
Published By
History
- Received October 15, 2018
- Revision received March 31, 2019
- Accepted April 18, 2019
- Published online April 26, 2019.
Copyright & Usage
Copyright © 2019 Govier-Cole et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Alistair E. Govier-Cole,
- Rhiannon J. Wood,
- Jessica L. Fletcher,
- David G. Gonsalvez,
- Daniel Merlo,
- Holly S. Cate,
- Simon S. Murray and
- Junhua Xiao
- Department of Anatomy and Neuroscience, University of Melbourne, Parkville 3010, Victoria, Australia
- Correspondence should be addressed to Junhua Xiao at Xiaoj{at}unimelb.edu.au or Simon Murray at Ssmurray{at}unimelb.edu.au.
Author contributions
Author contributions: A.E.G.-C., H.S.C., S.S.M., and J.X. designed research; A.E.G.-C., R.J.W., J.L.F., D.G.G., and D.M. performed research; A.E.G.-C., R.J.W., J.L.F., D.G.G., and D.M. analyzed data; A.E.G.-C., S.S.M., and J.X. wrote the paper.
Disclosures
The authors declare no competing financial interests.
A.E.G-C. is supported by an Australian National Health and Medical Research Council (NHMRC) Research Training Program scholarship. This work has been supported by a Multiple Sclerosis Research Australia Research Project Grant (#14-060 to H.S.C.) and NHMRC Project Grants (#APP1058647 to J.X.; APP1105108 to S.S.M.; APP1020735 to H.S.C.).
Funding
Australia National Health and Medical Research Council Project Grant
APP1058647; APP1105108Australian National Health and Medical Research Council Project Grant
APP1020735Multiple Sclerosis Research Australia Project Grant
#14-060Australian National Health and Medical Research Council Research Training Scholarship
N/AAustralian Research Council (ARC)
DP180102397
Other Version
- previous version (April 26, 2019).
- You are viewing the most recent version of this article.
Online Impact
Article usage
In this issue
Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation
